findmyKOL

Karin Katz, MD

Basic profile

New York University

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Karin Katz is an Endocrinology/Metabolic physician affiliated with New York University. OpenAlex indexes 15 publications with 448 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
15publications

Distinct works indexed by OpenAlex.

448citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    60.4%
    Insulin Analog20%
    Novolog Flexpen42%Lantus Solostar30%Levemir Flexpen14%Basaglar Kwikpen U-10014%
    Part D<11 patients
    Biguanide (metformin)18.8%
    Metformin Hcl Er53%Metformin Hcl47%
    Part D18 patients

    + 2 more classes in this area

  • Hormonal (systemic)

    28.5%
    l-Thyroxine23.7%
    Levothyroxine Sodium57%Synthroid43%
    Part D24 patients
    Thyroid Hormone Synthesis Inhibitor4.8%
    Methimazole100%
    Part D<11 patients
  • Sensory organs

    6.3%
    Corticosteroid6.3%
    Hydrocortisone100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”